NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 7,070.00
-740.00 (-9.48%)
Jul 28, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 95.27 billion as of July 28, 2026. Its market cap has decreased by -59.10% in one year.
Market Cap
95.27B
Enterprise Value
77.06B
Revenue
2.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,070.00
ChartMarket Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 95.27B, a decrease of -59.10%. That is a compound annual growth rate of -58.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 95.27B | -63.20% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.52T |
| Celltrion | 40.98T |
| ALTEOGEN | 16.71T |
| Samsung Epis Holdings | 9.74T |
| Genexine | 110.97B |
| Dongbang Medical | 110.95B |
| Jeil Pharma Holdings | 110.53B |
| Vaxcell-Bio Therapeutics | 92.10B |